A clinical trial found that twice-per-pregnancy STI screening reduced preterm birth risk by 23% versus standard care.
The US DHS added three BGI-linked genomics companies to the UFLPA Entity List, imposing import restrictions on certain lab ...
Clinisys has released an AI Innovation Roadmap to connect laboratory data, analytics, and automation, supporting workflow ...
Researchers developed a blood test using 10 biomarkers to help predict chronic disease risk and functional decline in adults.
LITMUS studies published in The Lancet and Nature Medicine validate blood and imaging tests for MASLD and MASH, reducing ...
Scipher Medicine plans early physician access for PrismTcell, a blood test to predict abatacept response in rheumatoid ...
A study found HPV testing detected high-grade cervical lesions missed by cytology in a cohort screened with CoSara’s assay.
A new Pennsylvania law mandates no-cost coverage of blood-based colorectal cancer screening for 2 million residents, aligning ...
Curiox Biosystems expands its leadership team and forms a Strategic Advisory Board to support growth of its centrifuge-free ...
Twist Bioscience launches Twist MRD Express, offering custom molecular residual disease panels with turnaround times starting ...
Malignant mesothelioma is a rare, life-threatening cancer that develops in the thin tissue lining internal organs, with more ...
Genefluence’s rapid PCR test for UTIs is now in clinical use, enabling one-hour detection of pathogens and resistance genes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results